$NNOXOct 15, 2026, 9:38 AM ETAI processed
Nanox's Nanox.ARC X named one of TIME's Best Inventions of 2026
AI Summary
Nanox (NNOX) said its Nanox.ARC X tomosynthesis X‑ray system was named one of TIME’s Best Inventions of 2026. The company notes the device is FDA‑cleared, captures up to 200 coronal images per scan with a claimed ~80% less radiation than CT, runs on standard 110V power with a smaller footprint and plug‑and‑play setup — the TIME recognition could boost commercial visibility as Nanox expands distribution, but the company still faces financial strain and uncertain market acceptance.
Positives
- Nanox.ARC X included on TIME’s Best Inventions of 2026 list (third‑party visibility/endorsement)
- Device is FDA‑cleared and marketed as delivering up to 200 coronal images per scan with ~80% less radiation than CT and a small footprint using standard 110V power
- Company reports distribution agreements across the US, Europe and Latin America and will showcase Nanox.ARC X at RSNA 2026
Negatives
- Company disclosure cites recurring losses, negative cash flows and substantial doubt about ability to continue as a going concern
- Market acceptance of the Nanox system and the company’s pay‑per‑scan business model remains unproven
- Commercialization risks remain, including manufacturing, regulatory and supply‑chain challenges